Skip to content
Global 2022
Asia-Pacific Region Corporate/M&A & Private Equity
Band 4

Chambers Review

Provided by Chambers
Corporate/M&A - Asia-Pacific Region
Band 4
What the team is known for

Jones Day has a strong regional bench, well placed to advise leading corporates on US-Asia M&A. Extensive regional presence with offices in China, Singapore, Japan, Australia and Taiwan. Also offers capability in India and Indonesia. Well known for its work acting for clients in the oil and gas, TMT and mining industries.

Notable practitioners

Mark Crean is a key contact for the firm's Australia corporate/M&A practice. Dennis Barsky and Elizabeth Cole lead the Singapore M&A team, while Gregory Salathé is a key contact in Japan. Shanghai-based Angel Huang, Beijing-based Jessie Tang and Charles Chau in Hong Kong are key contacts for the firm's Greater China practice. Tommy Chen and John Lin lead the Taiwan M&A practice.

Work Highlights

Provided by Jones Day
  • Jones Day advised OMERS Administration on its USD493 million acquisition of shares in ESR Cayman from an affiliate of Warburg Pincus.

  • Jones Day advised Sumitovant Biopharma on its USD217 million acquisition of all outstanding shares in Urovant Sciences, making Urovant a wholly owned subsidiary.
  • Jones Day advised the Queensland Investment Corporation on its AUD300 million participation in Bain Capital's AUD3.5 billion recapitalisation and acquisition out of administration of Virgin Australia.